Bionic pancreas study for cystic fibrosis related diabetes
Part of Hormones & metabolism clinical trials.
This trial tests if an automated insulin delivery system (the iLet bionic pancreas) can safely and effectively manage blood sugar in people with cystic fibrosis related diabetes (CFRD). If you have CFRD and already use insulin, this study may help you learn if a bionic pancreas works well for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 14 years old or older
- You have cystic fibrosis and have been diagnosed with CFRD (cystic fibrosis related diabetes) for at least 3 months and use insulin
- You have been on the same insulin routine (pump or injections) for at least 1 month and do not plan to change it during the study
- You use at least 0.1 units of insulin per kilogram of body weight each day
- You speak and read English well enough to use the pump and understand safety instructions
- You have a caregiver or emergency contact who can help if you have a serious low blood sugar event
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body handles sugar in people with cystic fibrosis related diabetes. Researchers want to learn more about glucose metabolism to improve care for people with CFRD.
This study uses a continuous glucose monitor (CGM), a small sensor worn on the skin, to track blood sugar levels in people with cystic fibrosis (CF) who do not have diabetes or have prediabetes. The goal is to find patterns that might predict who will develop diabetes, so it can be caught earlier.
This study tests if a continuous glucose monitor (CGM) along with a standard glucose drink test can better detect diabetes in people with cystic fibrosis. It is for adults who do not yet have diabetes and are generally healthy.
This trial studies whether a low glycemic load (a specific way of choosing carbohydrates) improves blood sugar control and body composition in adults with cystic fibrosis–related diabetes. It may help reduce blood sugar problems and support healthier weight and body measurements.
This study looks at how long-term diabetes affects people with cystic fibrosis. It helps researchers understand complications and improve care.
This study tests a drug called dorzagliatin to see if it can help control blood sugar in adults with cystic fibrosis who have pancreatic insufficiency and abnormal glucose tolerance.
Hear when a new Cystic Fibrosis-related Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.